Global Multiple Myeloma Drugs Sales Market Report 2018

多発性骨髄腫治療薬の世界市場

◆タイトル:Global Multiple Myeloma Drugs Sales Market Report 2018
◆商品コード:QYR802A3659
◆調査・発行会社:QYResearch
◆発行日:2017年12月26日
◆ページ数:105
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポート(2018年版)では、多発性骨髄腫治療薬の世界市場について調査・分析し、多発性骨髄腫治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、多発性骨髄腫治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・多発性骨髄腫治療薬市場概要
・多発性骨髄腫治療薬のメーカー別販売量・メーカー別シェア
・多発性骨髄腫治療薬の世界市場:種類別販売量・市場シェア
・多発性骨髄腫治療薬の世界市場:用途別販売量・市場シェア
・多発性骨髄腫治療薬の世界市場:地域別販売量・市場シェア
・多発性骨髄腫治療薬のアメリカ市場規模
・多発性骨髄腫治療薬の中国市場規模
・多発性骨髄腫治療薬のヨーロッパ市場規模
・多発性骨髄腫治療薬の日本市場規模
・多発性骨髄腫治療薬の東南アジア市場規模
・多発性骨髄腫治療薬のインド市場規模
・多発性骨髄腫治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・多発性骨髄腫治療薬のコスト分析・価格動向
・多発性骨髄腫治療薬の産業チェーン(サプライチェーン分析)
・多発性骨髄腫治療薬のマーケティング戦略・販売チャネル、流通業者
・多発性骨髄腫治療薬市場への影響要因分析
・多発性骨髄腫治療薬の世界市場予測
・多発性骨髄腫治療薬のアメリカ市場予測
・多発性骨髄腫治療薬の中国市場予測
・多発性骨髄腫治療薬のヨーロッパ市場予測
・多発性骨髄腫治療薬の日本市場予測
・多発性骨髄腫治療薬の東南アジア市場予測
・多発性骨髄腫治療薬のインド市場予測
・多発性骨髄腫治療薬の種類別世界市場予測
・多発性骨髄腫治療薬の用途別世界市場予測
...

In this report, the global Multiple Myeloma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Multiple Myeloma Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Multiple Myeloma Drugs market competition by top manufacturers/players, with Multiple Myeloma Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis
Bristol-Myers Squibb Company
Takeda Oncology
Johnson & Johnson
Celgene Corporation
Apotex
Emcure Pharmaceuticals
Amgen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Melphalan
Carmustine
Cyclophosphamide
Daratumumab
Doxorubicin Hydrochloride Liposome
Elotuzumab
Panobinostat
Other medication
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
applicaton 1
applicaton 2

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Multiple Myeloma Drugs Sales Market Report 2017
1 Multiple Myeloma Drugs Market Overview
1.1 Product Overview and Scope of Multiple Myeloma Drugs
1.2 Classification of Multiple Myeloma Drugs by Product Category
1.2.1 Global Multiple Myeloma Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Multiple Myeloma Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Melphalan
1.2.4 Carmustine
1.2.5 Cyclophosphamide
1.2.6 Daratumumab
1.2.7 Doxorubicin Hydrochloride Liposome
1.2.8 Elotuzumab
1.2.9 Panobinostat
1.2.10 Other medication
1.3 Global Multiple Myeloma Drugs Market by Application/End Users
1.3.1 Global Multiple Myeloma Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 applicaton 1
1.3.3 applicaton 2
1.4 Global Multiple Myeloma Drugs Market by Region
1.4.1 Global Multiple Myeloma Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.4.3 China Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.4.4 Europe Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.4.5 Japan Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.4.7 India Multiple Myeloma Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Multiple Myeloma Drugs (2012-2022)
1.5.1 Global Multiple Myeloma Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Multiple Myeloma Drugs Revenue and Growth Rate (2012-2022)

2 Global Multiple Myeloma Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Multiple Myeloma Drugs Market Competition by Players/Suppliers
2.1.1 Global Multiple Myeloma Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Multiple Myeloma Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Multiple Myeloma Drugs (Volume and Value) by Type
2.2.1 Global Multiple Myeloma Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Multiple Myeloma Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Multiple Myeloma Drugs (Volume and Value) by Region
2.3.1 Global Multiple Myeloma Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Multiple Myeloma Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Multiple Myeloma Drugs (Volume) by Application

3 United States Multiple Myeloma Drugs (Volume, Value and Sales Price)
3.1 United States Multiple Myeloma Drugs Sales and Value (2012-2017)
3.1.1 United States Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Multiple Myeloma Drugs Sales Price Trend (2012-2017)
3.2 United States Multiple Myeloma Drugs Sales Volume and Market Share by Players
3.3 United States Multiple Myeloma Drugs Sales Volume and Market Share by Type
3.4 United States Multiple Myeloma Drugs Sales Volume and Market Share by Application

4 China Multiple Myeloma Drugs (Volume, Value and Sales Price)
4.1 China Multiple Myeloma Drugs Sales and Value (2012-2017)
4.1.1 China Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Multiple Myeloma Drugs Sales Price Trend (2012-2017)
4.2 China Multiple Myeloma Drugs Sales Volume and Market Share by Players
4.3 China Multiple Myeloma Drugs Sales Volume and Market Share by Type
4.4 China Multiple Myeloma Drugs Sales Volume and Market Share by Application

5 Europe Multiple Myeloma Drugs (Volume, Value and Sales Price)
5.1 Europe Multiple Myeloma Drugs Sales and Value (2012-2017)
5.1.1 Europe Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Multiple Myeloma Drugs Sales Price Trend (2012-2017)
5.2 Europe Multiple Myeloma Drugs Sales Volume and Market Share by Players
5.3 Europe Multiple Myeloma Drugs Sales Volume and Market Share by Type
5.4 Europe Multiple Myeloma Drugs Sales Volume and Market Share by Application

6 Japan Multiple Myeloma Drugs (Volume, Value and Sales Price)
6.1 Japan Multiple Myeloma Drugs Sales and Value (2012-2017)
6.1.1 Japan Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Multiple Myeloma Drugs Sales Price Trend (2012-2017)
6.2 Japan Multiple Myeloma Drugs Sales Volume and Market Share by Players
6.3 Japan Multiple Myeloma Drugs Sales Volume and Market Share by Type
6.4 Japan Multiple Myeloma Drugs Sales Volume and Market Share by Application

7 Southeast Asia Multiple Myeloma Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Multiple Myeloma Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Multiple Myeloma Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Multiple Myeloma Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Multiple Myeloma Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Multiple Myeloma Drugs Sales Volume and Market Share by Application

8 India Multiple Myeloma Drugs (Volume, Value and Sales Price)
8.1 India Multiple Myeloma Drugs Sales and Value (2012-2017)
8.1.1 India Multiple Myeloma Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Multiple Myeloma Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Multiple Myeloma Drugs Sales Price Trend (2012-2017)
8.2 India Multiple Myeloma Drugs Sales Volume and Market Share by Players
8.3 India Multiple Myeloma Drugs Sales Volume and Market Share by Type
8.4 India Multiple Myeloma Drugs Sales Volume and Market Share by Application

9 Global Multiple Myeloma Drugs Players/Suppliers Profiles and Sales Data
9.1 Novartis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novartis Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bristol-Myers Squibb Company Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Takeda Oncology
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Oncology Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Johnson & Johnson
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Johnson & Johnson Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Celgene Corporation
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Celgene Corporation Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Apotex
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Apotex Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Emcure Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Emcure Pharmaceuticals Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Amgen
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Multiple Myeloma Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Amgen Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview

10 Multiple Myeloma Drugs Maufacturing Cost Analysis
10.1 Multiple Myeloma Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Multiple Myeloma Drugs
10.3 Manufacturing Process Analysis of Multiple Myeloma Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Multiple Myeloma Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Multiple Myeloma Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Multiple Myeloma Drugs Market Forecast (2017-2022)
14.1 Global Multiple Myeloma Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Multiple Myeloma Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Multiple Myeloma Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Multiple Myeloma Drugs Price and Trend Forecast (2017-2022)
14.2 Global Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Multiple Myeloma Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Multiple Myeloma Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Multiple Myeloma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Multiple Myeloma Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Multiple Myeloma Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Multiple Myeloma Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Multiple Myeloma Drugs Price Forecast by Type (2017-2022)
14.4 Global Multiple Myeloma Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Multiple Myeloma Drugs
Figure Global Multiple Myeloma Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Multiple Myeloma Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Melphalan Product Picture
Figure Carmustine Product Picture
Figure Cyclophosphamide Product Picture
Figure Daratumumab Product Picture
Figure Doxorubicin Hydrochloride Liposome Product Picture
Figure Elotuzumab Product Picture
Figure Panobinostat Product Picture
Figure Other medication Product Picture
Figure Global Multiple Myeloma Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Multiple Myeloma Drugs by Application in 2016
Figure applicaton 1 Examples
Table Key Downstream Customer in applicaton 1
Figure applicaton 2 Examples
Table Key Downstream Customer in applicaton 2
Figure Global Multiple Myeloma Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Multiple Myeloma Drugs Sales Volume (K Units) (2012-2017)
Table Global Multiple Myeloma Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Multiple Myeloma Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Multiple Myeloma Drugs Sales Share by Players/Suppliers
Figure 2017 Multiple Myeloma Drugs Sales Share by Players/Suppliers
Figure Global Multiple Myeloma Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Multiple Myeloma Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Multiple Myeloma Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Multiple Myeloma Drugs Revenue Share by Players
Table 2017 Global Multiple Myeloma Drugs Revenue Share by Players
Table Global Multiple Myeloma Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Multiple Myeloma Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Multiple Myeloma Drugs by Type (2012-2017)
Figure Global Multiple Myeloma Drugs Sales Growth Rate by Type (2012-2017)
Table Global Multiple Myeloma Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Multiple Myeloma Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Multiple Myeloma Drugs by Type (2012-2017)
Figure Global Multiple Myeloma Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Multiple Myeloma Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Multiple Myeloma Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Multiple Myeloma Drugs by Region (2012-2017)
Figure Global Multiple Myeloma Drugs Sales Growth Rate by Region in 2016
Table Global Multiple Myeloma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Multiple Myeloma Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Multiple Myeloma Drugs by Region (2012-2017)
Figure Global Multiple Myeloma Drugs Revenue Growth Rate by Region in 2016
Table Global Multiple Myeloma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Multiple Myeloma Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Multiple Myeloma Drugs by Region (2012-2017)
Figure Global Multiple Myeloma Drugs Revenue Market Share by Region in 2016
Table Global Multiple Myeloma Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Multiple Myeloma Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Multiple Myeloma Drugs by Application (2012-2017)
Figure Global Multiple Myeloma Drugs Sales Market Share by Application (2012-2017)
Figure United States Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table United States Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table United States Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Figure China Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table China Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table China Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Figure Europe Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table Europe Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table Europe Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Figure Japan Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table Japan Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table Japan Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Figure India Multiple Myeloma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Multiple Myeloma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Multiple Myeloma Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Multiple Myeloma Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Multiple Myeloma Drugs Sales Volume Market Share by Players in 2016
Table India Multiple Myeloma Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Multiple Myeloma Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Multiple Myeloma Drugs Sales Volume Market Share by Type in 2016
Table India Multiple Myeloma Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Multiple Myeloma Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Multiple Myeloma Drugs Sales Volume Market Share by Application in 2016
Table Novartis Basic Information List
Table Novartis Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Novartis Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Novartis Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Takeda Oncology Basic Information List
Table Takeda Oncology Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Oncology Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Takeda Oncology Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Takeda Oncology Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Celgene Corporation Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Celgene Corporation Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Apotex Basic Information List
Table Apotex Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Apotex Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Apotex Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Apotex Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Emcure Pharmaceuticals Basic Information List
Table Emcure Pharmaceuticals Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Emcure Pharmaceuticals Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Emcure Pharmaceuticals Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Emcure Pharmaceuticals Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Multiple Myeloma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Multiple Myeloma Drugs Sales Growth Rate (2012-2017)
Figure Amgen Multiple Myeloma Drugs Sales Global Market Share (2012-2017
Figure Amgen Multiple Myeloma Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Myeloma Drugs
Figure Manufacturing Process Analysis of Multiple Myeloma Drugs
Figure Multiple Myeloma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Myeloma Drugs Major Players in 2016
Table Major Buyers of Multiple Myeloma Drugs
Table Distributors/Traders List
Figure Global Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Myeloma Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Multiple Myeloma Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Multiple Myeloma Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Multiple Myeloma Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Multiple Myeloma Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Multiple Myeloma Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Multiple Myeloma Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Multiple Myeloma Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Multiple Myeloma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Multiple Myeloma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Multiple Myeloma Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Multiple Myeloma Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Multiple Myeloma Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Multiple Myeloma Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Multiple Myeloma Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Multiple Myeloma Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Multiple Myeloma Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[多発性骨髄腫治療薬の世界市場] (Global Multiple Myeloma Drugs Sales Market Report 2018 / QYR802A3659)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆